FDA clears brain mapping tool for neuromodulation therapies - Parkinson's News Today

FDA clears Turing Medical's Bullsai Identify, an AI-driven brain mapping tech for personalized neuromodulation therapy in Parkinson's disease, aiming to enhance treatment precision and reduce side effects.